Immunodiagnostic Market Growing Rapidly? Top Players: Abbott, DiaSorin and More Forecast till 2026
The Global Immunodiagnostics Market is expected to grow rapidly during the forecast period, owing to the increasing incidence & prevalence of infectious diseases such as cancer, respiratory infections, hepatitis, HIV infection, and other infectious diseases.
Pune, India – June 13, 2019 /MarketersMedia/ —
In terms of application, oncology and endocrinology segment held the largest share in the global immunodiagnostic market in 2017. Fortune Business Insights in its report, titled “Immunodiagnostics: Global Market Analysis, Insights and Forecast, 2018-2025” finds that the segment held nearly 25.6% of the global market in 2017. According to the report, the global immunodiagnostic market was valued at US$ 15,777.5 Mn in 2017. Moreover, the global market is forecasted to exhibit 4.7% CAGR and reach US$ 22,732.7 Mn by the end of 2025. In terms of product type, the regents and the consumable segment are expected to exhibit growth at a high pace during the forecast period 2018-2025.
Sample PDF Brochure at https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/immunodiagnostics-market-100444
KEY COMPANIES COVERED IN THE REPORT
• Abbott
• Hoffmann-La Roche AG (Roche Diagnostics)
• DiaSorin
• Danaher Corporation
• QIAGEN
• bioMérieux
• Thermo Fisher Scientific
• Quest Diagnostics
Immunodiagnostic is a new method to conduct analysis, hence its application reach is less at present. However, increasing adoption of immunodiagnostic in the diagnosis of cancer, endocrine disease, and others is likely to propel the demand in the global immunodiagnostic market.
Product launch and approval for new immunodiagnostic products and services are also expected to increase the growth rate in the global market. For instance, in 2017 the OPKO Health Inc. received approval from the U.S. Food and Drug Administration to conduct a full prostate-specific antigen text with immunoassay analyzer. Rising adoption of immunoassay analyzer will facilitate cost effectiveness and minimal steps diagnostic procedure. This is the chief driver of the market.
Rising Prevalence of Chronic Diseases to Drive the Global Market
The rising incidence of diseases such as HIV, respiratory, cancer, and others is likely to push the growth in the global immunodiagnostic market. Additionally, the growing geriatric population and favorable reimbursement policies are expected to drive the global immunodiagnostic market during the forecast period 2018-2025.
North America emerged dominant in the global immunodiagnostic market in 2017. Rising investment towards research and development to find novel therapeutics and diagnosis methods for the treatment of the aforementioned diseases are creating growth opportunities for the market in North America. Furthermore, government support towards these initiatives will augur well for the overall immunodiagnostics market. Asia Pacific also held a significant share in the global market. The Asia Pacific immunodiagnostic market was worth US$ 3939.1 Mn in 2017. The region is forecasted to progress at a higher CAGR. Moreover, a high potential for increasing penetration of immunodiagnostics in Asia Pacific will enable growth in the regional market.
Increasing purchasing power, technological advancements, and growing demand for quality healthcare services are key factors boosting the global immunodiagnostic market. Moreover, changing patient diagnostic preference towards minimal procedure is also anticipated to fuel the demand in the global market. On the downside, is lack of awareness about immunodiagnostics may restrain the market’s expansion in underdeveloped regions.
Browse Complete Report Details at https://www.fortunebusinessinsights.com/industry-reports/immunodiagnostics-market-100444
Major table of Content Followed by:
1.Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2.Executive Summary
3.Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
Strong Supply Chain Network to Facilitate Market Players
Abbott, Roche Diagnostics, Danaher Corporation, and DiaSorin are among the leading players in the global immunodiagnostic market. Growth witnessed by these organizations is facilitated by the presence of a robust supply chain network and their diverse product portfolio. Besides this, increasing investment in research and development activities and cost management by market players is helping organizations to gain a higher share in the global market. Some of the other organizations operating in the global immunodiagnostic market are QIAGEN, bioMérieux, Quest Diagnostics, and Thermo Fisher Scientific.
View More Related Reports
Contact Info:
Name: Fortune Business Insights
Email: Send Email
Organization: Fortune Business Insights
Address: Fortune Business Insights Pvt. Ltd., 308, Supreme Headquarters,, Survey No. 36, Baner,, Pune-Bangalore Highway,, Pune – 411045, Maharashtra, India.
Phone: 4242530390
Website: https://www.fortunebusinessinsights.com
Source: MarketersMedia
Release ID: 523787
Copyright © 1999-2013 SproutNews.com
